Teleflex (TFX)

NYSE Health Care Health Care Equipment S&P SmallCap 600
$150.87
-1.28 (-0.84%)
Close of Nov 06, 2026 · end-of-day data
Source: Teleflex's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$1.87B$2.15B$2.45B$2.60B$2.54B$2.81B$2.79B$1.71B$1.70B$1.99B
Cost of revenue$871.83M$974.50M$1.15B$1.19B$1.21B$1.26B$1.26B$672.33M$662.16M$871.96M
Gross profit$996.20M$1.17B$1.30B$1.41B$1.32B$1.55B$1.53B$1.04B$1.04B$1.12B
Research & development$58.58M$84.77M$106.21M$113.86M$119.75M$130.84M$153.82M$113.63M$109.02M$144.78M
Selling, general & admin$563.31M$699.96M$797.06M$851.77M$743.57M$860.09M$863.75M$622.74M$674.52M$720.17M
Operating income$319.45M$372.28M$321.70M$427.25M$423.07M$628.10M$499.73M$258.73M$103.65M$118.37M
Interest expense$54.94M$82.55M$103.02M$80.27M$66.49M$56.97M$54.26M$85.08M$83.51M$100.22M
Pre-tax income$245.72M$284.91M$219.63M$339.90M$357.73M$559.47M$445.92M$185.39M$26.29M$24.55M
Income tax$8.07M$129.65M$23.20M-$122.08M$21.93M$74.35M$83.00M$41.87M-$30.90M-$33.98M
Net income$237.38M$152.53M$200.80M$461.47M$335.32M$485.37M$363.14M$356.33M$69.67M-$905.64M
EBITDA$447.80M$532.62M$536.42M$645.62M$650.32M$865.46M$730.32M$406.83M$265.19M$296.11M
EPS (basic)$5.48$3.39$4.39$9.99$7.21$10.38$7.74$7.58$1.49$-20.30
EPS (diluted)$4.98$3.27$4.29$9.80$7.09$10.23$7.68$7.53$1.48$-20.25
Diluted shares47.65M46.66M46.80M47.09M47.29M47.43M47.31M47.30M47.09M44.72M
Gross margin53.3%54.6%53.2%54.3%52.2%55.2%54.9%60.7%61.0%56.2%
Operating margin17.1%17.3%13.1%16.5%16.7%22.4%17.9%15.1%6.1%5.9%
Net margin12.7%7.1%8.2%17.8%13.2%17.3%13.0%20.8%4.1%-45.4%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$543.79M$333.56M$357.16M$301.08M$375.88M$445.08M$292.03M$222.85M$247.85M$378.56M
Receivables$271.99M$345.88M$366.29M$418.67M$395.07M$383.57M$408.83M$443.47M$226.73M$345.58M
Inventory$316.17M$395.74M$427.78M$476.56M$513.20M$477.64M$578.51M$626.22M$306.77M$404.39M
Total current assets$1.18B$1.13B$1.24B$1.31B$1.42B$1.43B$1.41B$1.41B$1.47B$1.94B
Goodwill$1.28B$2.24B$2.25B$2.25B$2.59B$2.50B$2.54B$2.91B$1.99B$2.31B
Total assets$3.89B$6.18B$6.28B$6.31B$7.15B$6.87B$6.93B$7.53B$7.10B$6.95B
Total current liabilities$427.65M$483.88M$582.46M$563.05M$540.03M$680.12M$581.49M$606.75M$649.36M$762.03M
Short-term debt$183.07M$86.62M$86.62M$50.00M$100.50M$110.00M$87.50M$87.50M$100.00M$100.00M
Long-term debt$850.25M$2.16B$2.07B$1.86B$2.38B$1.74B$1.62B$1.73B$1.56B$2.54B
Total debt$1.03B$2.25B$2.16B$1.91B$2.48B$1.85B$1.71B$1.82B$1.66B$2.64B
Total liabilities$1.75B$3.75B$3.74B$3.33B$3.82B$3.12B$2.91B$3.09B$2.82B$3.82B
Shareholders' equity$2.14B$2.43B$2.54B$2.98B$3.34B$3.75B$4.02B$4.44B$4.28B$3.12B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$410.59M$426.30M$435.09M$437.07M$437.14M$652.14M$342.81M$206.14M$301.88M$96.68M
Capital expenditures$53.13M$70.90M$80.80M$102.69M$90.69M$71.62M$79.19M$46.42M$90.44M$95.24M
Free cash flow$357.45M$355.40M$354.29M$334.37M$346.45M$580.52M$263.62M$159.72M$211.44M$1.45M
Investing cash flow-$56.97M-$1.83B-$196.39M-$73.48M-$837.78M$156.74M-$259.41M$27.26M-$63.36M-$812.65M
Financing cash flow-$118.69M$1.14B-$206.43M-$418.84M$455.16M-$715.82M-$217.51M$38.54M-$421.93M$611.54M
Dividends paid$58.96M$61.24M$62.16M$62.83M$63.22M$63.65M$63.79M$63.90M$63.54M$60.27M
Share buybacks——————$0$0$200.00M$300.00M
Stock-based compensation$16.87M$19.41M$22.44M$26.94M$20.74M$22.94M$27.22M$27.30M$25.96M$25.70M
Depreciation & amortization$128.35M$160.34M$214.71M$218.37M$227.25M$237.36M$230.59M$148.10M$161.53M$177.74M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.